In this large retrospective cohort, we aimed to re-evaluate the TP53 status as prognostic factor in WNT-MBs, and to screen for chromosomal aberrations and other biomarkers as possible prognostic factors. The gene discussed is TP53; the disease is Mobius syndrome.